This stock may be hazardous to your financial health | Talking Numbers - Yahoo Finance
The company will demonstrate two personal health journeys, featuring ecosystem partners BioIQ, Wildflower Health, Brain Resource, MotiveMI, Wellsource, and MapMyFitness, as well as the IBM Watsons cognitive computing capabilities. Over the years weve learned that to really understand how effective new care models can be, you have to experience them in person, says Tom Main, partner and U.S. market leader for the Health & Life Sciences practice of Oliver Wyman and managing director of OWHIC. Its not practical to fly our guests all over the country to view the best that U.S. healthcare has to offer, so instead we are bringing the best of U.S. healthcare to Tampa. Youd have to spend weeks and travel thousands of miles to get the experience were providing over the course of a few days. This September, Tampa will be the epicenter of medical innovation, said Rick Homans, President and CEO of the Tampa Hillsborough Economic Development Corporation.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/healthcare-trillion-dollar-transformation-comes-140000791.html
By Zacks Equity Research 1 hour ago 0 shares Content preferences Done As per a news report from Bloomberg, Switzerland-based oncology major, Roche ( RHHBY ) is set to buy the remaining 39.5% stake in its Japanese subsidiary, Chugai Pharmaceutical Co Ltd, for approximately $10 billion. As of Jun 30, 2014, Roche owned a 61.5% stake in Chugai. The buyout will make Chugai a fully-owned subsidiary of Roche. We note that Roche has been active on the acquisition front in recent times. Earlier in the month, Roche announced that it has entered into an agreement to acquire Denmark-based privately-held biopharmaceutical company, Santaris Pharma. Last month, Roche entered into a definitive agreement to acquire privately-held biotechnology company, Seragon Pharmaceuticals, Inc. The acquisition will provide Roche rights to Seragons entire portfolio of investigational next-generation oral selective estrogen receptor degraders (SERDs) for the potential treatment of hormone receptor-positive breast cancer. The recent acquisitions will further strengthen Roches deep pipeline. Roche is well placed in the oncology market.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/roche-rhhby-buy-remaining-stake-205502367.html
UTi Worldwide and Ansell Name Safmarine "Partner of the Year" - Yahoo Finance
And until those questions are answered, I dont think that the drug Brilinta will come anywhere close to the $3.5 billion in revenue that was originally projected. Lichtenfeld is referring to a paper in the International Journal of Cardiology written by two doctors that was critical of AstraZenecas Brilinta trials. As it now stands, Lichtenfeld thinks AstraZeneca is overpriced relative to other pharmaceutical companies. Theres not a lot to like here, Lichtenfeld said. Sure, there are some clinical trials and some data that came out recently. But all the big pharmas have decent clinical trials coming out. They all have big pipelines. I think there area lot better opportunities out there. View gallery .
For the original version including any supplementary images or video, visit http://finance.yahoo.com/blogs/talking-numbers/this-stock-may-be-hazardous-to-your-financial-health-222747334.html
Will Roche (RHHBY) Buy the Remaining Stake in Chugai? - Yahoo Finance
Ansell's relationship with UTi now enters its 10th year. "Safmarine proved to be our most supportive ocean carrier, in terms of their understanding of what we need in a logistics partnership. Safmarine has consistently delivered reliable service," said Andrew Gillespie, Ansell's director of global logistics. Since 2005, Safmarine, in support of UTi, has connected Ansell's manufacturing bases in Sri Lanka and Malaysia to their customers around the world, according to Diane Bennett, UTi's senior vice president, Procurement. "Safmarine plays a critical role in supporting our client's business particularly in the Indian Sub-Continent, Europe and North America regions," she added. In delivering the award to Arthur Bredehoft, Bennett praised Safmarine for being proactive and innovative while always putting customers first. About UTi Worldwide UTi Worldwide Inc.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/uti-worldwide-ansell-name-safmarine-071023277.html